Login

KL Acquisition Corp

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 21, 2022. Its latest SEC filing is a SC 13G/A from Feb 14, 2023.

The sections below describe the company as of the FY2021 annual report.

What Did They Do?

Seeks to acquire and build healthcare businesses, focusing on medical devices, diagnostics, and life-sciences tools and instrumentation.

How Did They Make Money?

No revenue was reported.

How Were They Changing?

Since the FY2021 annual report
Latest quarter: Q3 FY2022, the three months to Sep 30, 2022
Net income
▼ −28%
vs $3.2M in Q3 FY2021
  • Dec 20, 2022 Company sets an early termination date and proceeds toward liquidation and delisting After stockholder approval, the company suspended trading and expected to redeem remaining public shares before dissolution.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support